Rocket Lab has solid sell-side coverage, though the October 2026 selloff tied to the Neutron delay prompted several estimate resets. The $100 central target reflects the average of nine recent attributed forecasts reviewed after that news: Cantor Fitzgerald at $122, Stifel at $132, Needham at $120, Roth Capital at $110, Clear Street at $105, KeyBanc at $100, Citizens at $90, Raymond James at $80, and Goldman Sachs at $67. The simple average comes to roughly $103 before rounding down to $100, spanning a broad $67-to-$132 band.
Broader aggregator data from about 19 to 21 analysts shows an average target still in the low $100s, with a consensus leaning mostly Buy or Strong Buy and just a few Holds and no Sells. The spread highlights differing views on how much the Neutron timeline shift truly matters long term.
Rocket Lab Corporation (RKLB) focuses on Electron rocket launches, spacecraft systems, and on-orbit services. Shares closed near $53.67 on October 21, 2026, down about 65% from the 52-week high of $151.00 and sitting below both the 50-day and 200-day moving averages. Hitting $100 would mean an 86% advance, a substantial re-rating for a business that has yet to turn consistently profitable.
Trailing twelve-month revenue reached roughly $769 million, up more than 50% year over year, while the backlog hit a record $2.36 billion. Net losses remain around $165 million over the past year, and the stock trades near 53 times sales—an ambitious multiple for a pre-profit launch operator. Much of the upside case rests on Neutron, the planned reusable medium-lift vehicle with far greater capacity than Electron.
The core growth narrative continues to hold. Launch demand stays robust, and the company’s Electron flight cadence, multiple sites, and mix of commercial and government customers provide a solid base. Major contracts include roughly $663 million in U.S. Space Force awards and a 20-launch deal with Synspective. Third-quarter revenue guidance sits at $250–$265 million, and the backlog has more than doubled year over year. A successful Neutron debut could prompt upward re-ratings from analysts who view the medium-lift segment as expanding. I also checked comparable names using Tickeron’s AI Screener to see how Rocket Lab stacks up on growth metrics.
Execution remains the primary hurdle. Neutron’s first launch slipped from late 2026 into 2027 after engineers discovered voids in the carbon-composite tank dome, requiring a rebuild. Several firms lowered targets post-delay while keeping Buy ratings. The company continues to burn cash, and positive free cash flow is not expected until well after Neutron’s initial success. An $8 billion Iridium Communications acquisition adds further integration and financing questions. Any prolonged delay or test setback could pressure the current valuation further.
The recent decline marks one of the sharpest drawdowns in the stock’s history. The 52-week range runs from $37.57 to $151.00, with the prior high serving as distant resistance. Support near $50 and the 52-week low around $37.57 mark important lower levels. Trading below both moving averages keeps the intermediate trend negative, so any sustained move toward $100 would first need to reclaim the mid-$60s and then the $80s. A five-year beta near 2.9 highlights the elevated volatility relative to the broader market.
Most analyst targets cover a roughly 12-month horizon, though updates occur frequently. The next earnings release, expected in early November, will show whether third-quarter results align with guidance and whether the backlog keeps expanding. Key items to track include Neutron manufacturing progress, any revised launch timing, updates on the Iridium deal, additional contract wins, and further target revisions. Broader interest-rate moves and risk sentiment will also influence this high-beta name.
I occasionally reference Tickeron’s AI Daily Buy/Sell Signals when reviewing volatile names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical and market-condition shifts. For a stock with wide price swings, it offers an efficient way to flag potential changes alongside traditional analysis.
In my own research process I find Tickeron’s AI Daily Buy/Sell Signals helpful for tracking momentum shifts in growth-oriented names. The platform continuously analyzes market data and technical patterns, which can complement fundamental work when following companies with complex execution timelines. It is one of several resources I use to stay organized without replacing independent judgment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend. In 21 of 23 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In 72 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for RKLB turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, 27 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 260 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 201 of 240 cases where RKLB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.827) is normal, around the industry mean (4.905). RKLB's P/E Ratio (-198.778) is considerably lower than the industry average of (16.553). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.330).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 73 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense